Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-24,315
Closed -$846K 913
2024
Q3
$846K Hold
24,315
﹤0.01% 684
2024
Q2
$787K Sell
24,315
-155
-0.6% -$5.17K ﹤0.01% 675
2024
Q1
$831K Sell
24,470
-2,328
-9% -$88.6K ﹤0.01% 661
2023
Q4
$1.06M Hold
26,798
0.01% 661
2023
Q3
$1.02M Hold
26,798
0.01% 673
2023
Q2
$1.22M Sell
26,798
-45
-0.2% -$2.1K 0.01% 688
2023
Q1
$1.2M Hold
26,843
0.01% 787
2022
Q4
$1.18M Hold
26,843
0.01% 845
2022
Q3
$1.13M Buy
26,843
+75
+0.3% +$3.64K 0.01% 928
2022
Q2
$1.32M Buy
26,768
+3,280
+14% +$176K 0.01% 961
2022
Q1
$1.3M Buy
23,488
+304
+1% +$16.1K ﹤0.01% 974
2021
Q4
$1.21M Buy
+23,184
New +$1.19M ﹤0.01% 966

Other funds holding BCE

Calamos Advisors's BCE Position: Q4 2024 in Review

Calamos Advisors sold out of BCE (BCE) in Q4 2024, closing a stake of 24,315 shares — an estimated $846K sold.

Calamos Advisors first reported a position in BCE in Q4 2021 and held it in 12 quarters. The position peaked at $1.32M in Q2 2022. 430 funds tracked by Wall St. Rank hold BCE as of Q4 2024.

  • Calamos Advisors reported no remaining BCE position as of Q4 2024 after selling out during the quarter.
  • Calamos Advisors sold 24,315 BCE shares in Q4 2024, an estimated $846K.
  • Calamos Advisors first reported a position in BCE in Q4 2021 and held it in 12 quarters.
  • Calamos Advisors's BCE position peaked at $1.32M in Q2 2022.
  • 430 funds tracked by Wall St. Rank held BCE as of Q4 2024.

Based on Calamos Advisors's 13F filing for Q4 2024, filed 24 Jan 2025.